PMA P050047S079

Device
Juvéderm Ultra, Juvéderm Ultra XC, Juvéderm Ultra Plus, and Juvéderm Ultra Plus XC
Applicant
Allergan
PMA number
P050047
Supplement
S079
Product code
LMH
Decision date
2020-11-25
Generic name
Implant, dermal, for aesthetic use
Approval order statement
Approval for revisions to the patient labeling of Juvéderm® Ultra, Juvéderm® Ultra Plus, Juvéderm® Ultra XC Wrinkles and Folds, Juvéderm® Ultra XC Lips, and Juvéderm® Ultra Plus XC to include updated safety information based on post marketing surveillance data.

Current openFDA PMA Record#

Device
Juvéderm Ultra, Juvéderm Ultra XC, Juvéderm Ultra Plus, and Juvéderm Ultra Plus XC
Applicant
Allergan
PMA number
P050047
Supplement
S079
Product code
LMH
Generic name
Implant, dermal, for aesthetic use
Decision date
2020-11-25
Decision code
APPR
Date received
2020-10-30
Supplement type
Special (Immediate Track)
Supplement reason
Labeling Change - Indications/instructions/shelf life/tradename
Approval order statement
Approval for revisions to the patient labeling of Juvéderm® Ultra, Juvéderm® Ultra Plus, Juvéderm® Ultra XC Wrinkles and Folds, Juvéderm® Ultra XC Lips, and Juvéderm® Ultra Plus XC to include updated safety information based on post marketing surveillance data.